AstraZeneca improves diabetes pen to maintain its market shareThe European Commission (EC) has approved AstraZeneca’s Bydureon BCise, a new weekly formulation of established GLP-1 diabetes drug Share XAstraZeneca improves diabetes pen to maintain its market sharehttps://pharmaphorum.com/news/astrazeneca-improves-diabetes-pen-to-maintain-its-market-share/
